Is ticagrelor worth its high cost and side-effects?

RA Guerbaai, I Mahata, S Maréchaux… - Acta …, 2019 - Taylor & Francis
Ticagrelor is a reversible P2Y12 receptor antagonist that is more potent than clopidogrel.
When used in combination with aspirin, it reduces cardiovascular events in patients with …
被引用次数：16 相关文章

Is ticagrelor worth its high cost and side-effects?

RA Guerbaai, I Mahata, S Maréchaux… - Acta …, 2018 - europepmc.org
Ticagrelor is a reversible P2Y12 receptor antagonist that is more potent than clopidogrel.
When used in combination with aspirin, it reduces cardiovascular events in patients with …

Is ticagrelor worth its high cost and side-effects?

RA Guerbaai, I Mahata, S Maréchaux… - Acta …, 2019 - pubmed.ncbi.nlm.nih.gov
Ticagrelor is a reversible P2Y 12 receptor antagonist that is more potent than clopidogrel.
When used in combination with aspirin, it reduces cardiovascular events in patients with …

Is ticagrelor worth its high cost and side-effects?

RA Guerbaai, I Mahata, S Marechaux… - Acta …, 2019 - u-picardie.hal.science
Ticagrelor is a reversible P2Y (12) receptor antagonist that is more potent than clopidogrel.
When used in combination with aspirin, it reduces cardiovascular events in patients with …

Is ticagrelor worth its high cost and side-effects?

RA Guerbaai, I Mahata, S Maréchaux, TH Le Jemtel… - Acta …, 2019 - folia.unifr.ch
English Ticagrelor is a reversible P2Y12 receptor antagonist that is more potent than
clopidogrel. When used in combination with aspirin, it reduces cardiovascular events in …

Is ticagrelor worth its high cost and side-effects?

RA Guerbaai, I Mahata, S Maréchaux, TH Le Jemtel… - Acta cardiologica, 2019 - sonar.ch
English Ticagrelor is a reversible P2Y12 receptor antagonist that is more potent than
clopidogrel. When used in combination with aspirin, it reduces cardiovascular events in …

Is ticagrelor worth its high cost and side-effects?

RA Guerbaai, I Mahata, S Maréchaux… - Acta …, 2019 - edoc.unibas.ch
Ticagrelor is a reversible P2Y; 12; receptor antagonist that is more potent than clopidogrel.
When used in combination with aspirin, it reduces cardiovascular events in patients with …

Is ticagrelor worth its high cost and side-effects?

RA Guerbaai, I Mahata, S Marechaux, TH Le Jemtel… - Acta …, 2019 - hal.science
Ticagrelor is a reversible P2Y (12) receptor antagonist that is more potent than clopidogrel.
When used in combination with aspirin, it reduces cardiovascular events in patients with …